Results 191 to 200 of about 7,219 (278)

Multi‐Parametric Magnetic Resonance Imaging to Assess Empagliflozin Effect on the Kidneys in People With Type 2 Diabetes Mellitus: A Pilot Clinical Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7416-7429, August 2026.
ABSTRACT Aims Empagliflozin is renoprotective in Type 2 diabetes mellitus (T2DM). Our primary aim was to assess empagliflozin's effect on glomerular filtration rate and renal vascular resistance using multiparametric MRI (MpMRI). Our secondary aim was to assess the impact of empagliflozin on additional MpMRI‐derived metrics including markers of tissue ...
Ruth P. Lim   +9 more
wiley   +1 more source

An Evaluation of AI‐Generated Clinical Notes in the OpenNotes Era: A Thematic Analysis of Clinician Discourse

open access: yesJournal of Evaluation in Clinical Practice, Volume 32, Issue 5, August 2026.
ABSTRACT Background The integration of ambient artificial intelligence (AI) scribes into the OpenNotes environment presents a profound governance crisis in healthcare. While patient access to medical records was designed as a transparency reform, the introduction of machine‐generated text introduces novel vulnerabilities regarding record integrity ...
Samuel Atiku, Olufisayo Olakotan
wiley   +1 more source

Arterial NALCN Knockdown Ameliorates Mineralocorticoid-Induced Hypertension and Arterial Overcontractility. [PDF]

open access: yesCirc Res
Lee H   +11 more
europepmc   +1 more source

Potassium binders and continuation of renin–angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)

open access: yesJournal of Internal Medicine, Volume 300, Issue 2, Page 179-192, August 2026.
Abstract Introduction Hyperkalaemia is a serious complication in patients with chronic kidney disease (CKD) and heart failure (HF), often leading to the discontinuation of renin–angiotensin–aldosterone system inhibitors (RAASi; renin‐angiotensin system inhibitors [RASi] and mineralocorticoid receptor antagonists [MRAs]) despite their cardiorenal ...
Hans Furuland   +6 more
wiley   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

open access: yesJournal of Internal Medicine, Volume 300, Issue 2, Page 204-212, August 2026.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen   +11 more
wiley   +1 more source

Case Report: Autoimmune hepatitis in a patient with pseudohypoaldosteronism type 1-insights into a rare co-occurrence. [PDF]

open access: yesFront Pediatr
Al Thiabat H   +6 more
europepmc   +1 more source

Intermittent Fasting Exerts Antidepressant‐Like Effects by Restoring HPA Axis Homeostasis Through Coordinated GR–MR Signaling

open access: yesThe FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Intermittent fasting (IF) exerts antidepressant‐like effects by restoring impaired cooperative signaling between glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), thereby modulating hypothalamic neurocircuit activity and reinstating HPA axis homeostasis.
Miaomiao Tang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy